Loading…
RxSight, Inc. is projected to rise to $6.89 by 2027, a +15% move from its current price of $6.01. RXST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.80 | $6.01 | $6.23 | +0.02% |
| Aug 4 | $5.71 | $6.01 | $6.33 | +0.03% |
| Aug 5 | $5.65 | $6.01 | $6.40 | +0.05% |
| Aug 6 | $5.60 | $6.01 | $6.46 | +0.06% |
| Aug 7 | $5.55 | $6.01 | $6.52 | +0.08% |
| Aug 8 | $5.51 | $6.02 | $6.57 | +0.10% |
| Aug 9 | $5.47 | $6.02 | $6.62 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.47 | $6.02 | $6.62 | +0.11% |
| Week 2 | $5.26 | $6.02 | $6.89 | +0.23% |
| Week 3 | $5.11 | $6.03 | $7.11 | +0.34% |
| Week 4 | $4.99 | $6.04 | $7.30 | +0.45% |
| Week 5 | $4.89 | $6.04 | $7.48 | +0.57% |
| Week 6 | $4.79 | $6.05 | $7.64 | +0.68% |
| Week 7 | $4.71 | $6.06 | $7.79 | +0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
RxSight, Inc. is a commercial-stage medical technology company that engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers the RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The RxSight system includes the RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to patterns of ultraviolet light, which can be adjusted to achieve the desired vision after surgery; and the RxSight light delivery device, an office-based device that delivers UV light to modify the LAL.
RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
RxSight, Inc. trades at $6.05 per share, and has a market capitalization of $250.45M. It is ranked 3491.
The near-term forecast for 2026 shows a min of $4.59, an average of $6.05, and a max of $7.96, with a Neutral sentiment attached to that year.
Looking further out, the forecast envisions higher averages in later years, with 2032 (avg $9.53) and 2050 (avg $25.54) as notable milestones supported by strong ROI projections, including 57.5% in 2032 and 322.2% in 2050.
A major floor 29.7% below — a decisive break under it would weaken the trend.
The nearest floor, 21.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 26.6% above — clearing it would confirm fresh momentum.
Key RXST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RXST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.98 | Buy | $5.93 | Buy |
| MA 10 | $5.67 | Buy | $5.76 | Buy |
| MA 20 | $5.48 | Buy | $5.57 | Buy |
| MA 50 | $5.31 | Buy | $5.59 | Buy |
| MA 100 | $6.04 | Sell | $6.23 | Sell |
| MA 200 | $7.84 | Sell | $8.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.40 | Neutral |
| Stoch RSI (14) | 85.42 | Sell |
| CCI (20) | 115.95 | Buy |
| Williams %R (14) | -9.92 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 14.48 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 90.08 | Sell |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.69 | Buy |
| Ultimate (7,14,28) | 70.58 | Sell |
| Momentum (10) | 0.46 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 6.27 | Sell |
| ADX (14) | 14.37 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is described as BULLISH. The RSI14 is 60. The 50-day simple moving average (SMA50) is $5.29 and the 200-day simple moving average (SMA200) is $7.87. Support is at $4.59 and resistance at $6.05. The 30-day price range is $4.67 to $7.84, reflecting near-term volatility.
Annualized volatility is 80%, underscoring a relatively high level of price fluctuation over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.59 | $6.01 | $7.79 | 0% | Neutral | |
| $5.34 | $6.89 | $9.50 | +15% | Neutral | |
| $4.95 | $6.64 | $9.59 | +10% | Neutral | |
| $4.73 | $6.55 | $9.82 | +9% | Neutral | |
| $4.92 | $7.02 | $10.84 | +17% | Neutral | |
| $5.28 | $7.73 | $12.27 | +29% | Bullish | |
| $6.65 | $9.97 | $16.20 | +66% | Bullish | |
| $6.78 | $10.41 | $17.27 | +73% | Bullish | |
| $5.83 | $9.15 | $15.48 | +52% | Bullish | |
| $6.30 | $10.09 | $17.39 | +68% | Bullish | |
| $8.12 | $14.37 | $26.67 | +139% | Bullish | |
| $13.47 | $28.44 | $58.75 | +373% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.59 | $6.01 | $7.41 | +0.00% |
| September 2026 | $5.26 | $6.28 | $7.75 | +4.43% |
| October 2026 | $5.06 | $6.10 | $7.63 | -2.82% |
| November 2026 | $4.87 | $5.92 | $7.49 | -3.01% |
| December 2026 | $4.99 | $6.09 | $7.79 | +3.01% |
Click any year to see its month-by-month RXST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RXST is projected to trade between $4.59 and $7.79, averaging $6.01 — a potential gain of 0% from today's $6.01. Price action looks broadly range-bound.
RxSight, Inc.'s 2027 outlook centres on $6.89, within a $5.34 to $9.50 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, RXST could reach as high as $9.59, with a base case around $6.64 and support toward $4.95 — roughly +10% from $6.01. Price action looks broadly range-bound.
Expect RXST to range from $4.73 to $9.82 through 2029. The $6.55 average target implies a +9% move from current prices. That is -1% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The RXST price prediction for 2030 points to an average of $7.02 (low $4.92, high $10.84) — a potential gain of +17% on today's $6.01. Price action looks broadly range-bound.
In 2031, RXST is projected to trade between $5.28 and $12.27, averaging $7.73 — a potential gain of +29% from today's $6.01. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
RxSight, Inc.'s 2032 outlook centres on $9.97, within a $6.65 to $16.20 range. That is up +29% on the projected 2031 average. That marks a +66% change versus current levels. Momentum favours further upside here.
By 2033, RXST could reach as high as $17.27, with a base case around $10.41 and support toward $6.78 — roughly +73% from $6.01. Buyers look set to stay in control over this stretch.
Expect RXST to range from $5.83 to $15.48 through 2034. The $9.15 average target implies a +52% move from current prices. That is -12% versus the projected 2033 average. Momentum favours further upside here.
The RXST price prediction for 2035 points to an average of $10.09 (low $6.30, high $17.39) — a potential gain of +68% on today's $6.01. Buyers look set to stay in control over this stretch.
In 2040, RXST is projected to trade between $8.12 and $26.67, averaging $14.37 — a potential gain of +139% from today's $6.01. That is up +42% on the projected 2035 average. Momentum favours further upside here.
RxSight, Inc.'s 2050 outlook centres on $28.44, within a $13.47 to $58.75 range. That is up +98% on the projected 2040 average. That marks a +373% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in RXST today (≈ 166.389351 RXST) could be worth
$4,731.36
+$3,731.36 (+373%) by 2050 · US Dollar
Based on the average projected RXST price of $28.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RXSTwould be worth at today's price.
$1,000 invested in RXST on Jul 31, 2025 (≈ 128.534701 RXST) would be worth
$772.49
-$227.51 (-22.8%) today · 0.77× · US Dollar
Based on a RXST entry price of $7.78 vs. today's $6.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.19 | $1,158 | +15.8% |
| 1 month ago | $5.17 | $1,162.48 | +16.2% |
| 3 months ago | $7.4 | $812.16 | -18.8% |
| 6 months ago | $8.83 | $680.63 | -31.9% |
| 1 year ago | $7.78 | $772.49 | -22.8% |
| All time (5.0y) ago | $16.35 | $367.58 | -63.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RXST forecast.
Our base-case forecast reaches $12.00 around 2040.
Implied market cap at $12.00: $496.76M
The multi-year outlook shows a transition from Neutral in the near years to more bullish territory in later years. In 2026, the average price is forecast at $6.05 with a Neutral sentiment. In 2027, the average price is forecast at $6.91 with a 14.3% ROI and Neutral sentiment; in 2028 the average is $6.56 with 8.5% ROI; in 2029 the average is $6.36 with 5.1% ROI, all with Neutral sentiment.
From 2032 onward, the forecast turns more favorable, with a 2032 average of $9.53 and a 57.5% ROI, and a 2033 average of $9.84 with a 62.6% ROI and Bullish sentiment. The 2040 forecast shows an average of $13.09 with a 116.4% ROI, and the 2050 forecast shows an average of $25.54 with a 322.2% ROI and Bullish sentiment.
Max forecast prices grow considerably in later years: 2032 max $15.89, 2033 max $16.78, 2040 max $25.15, and 2050 max $54.91. These figures are estimates and not guarantees, and they reflect potential upside alongside significant risk and volatility.
Tap a question to reveal the answer.
For 2030, the forecast shows min $4.54, avg $6.63, max $10.48, with an ROI of 9.5% and Neutral sentiment.
The near-term outlook is Neutral in 2026 with modest upside in later years. The forecast lists several positive ROI milestones, including 14.3% in 2027, 57.5% in 2032, and 322.2% in 2050, but these are estimates and not guarantees.
The forecast shows 2040 max $25.15 and 2050 max $54.91, with intermediate years like 2032 max $15.89 and 2033 max $16.78. Reaching $20 appears possible in later years, depending on market conditions.
Current price is $6.05 and market cap is $250.45M.
In 2032, the average forecast price is $9.53 with a min of $6.17 and a max of $15.89, and a ROI of 57.5% with a Bullish sentiment.
RxSight, Inc. Community Discussion
0Share your RxSight, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.